Circumventing the genetic susceptibility of tamoxifen through pro-drug principle / Nouran Moustafa Hussein Elsawaf ; Supervised Ashraf H. Abadi , Nermin Salah Ahmed

By:

Nouran Moustafa Hussein Elsawaf

Contributor(s):

Material type: Text

TextLanguage: English Publication details: Cairo : Nouran Moustafa Hussein Elsawaf , 2016Description: 101 Leaves ; 30cmOther title:

التحايل على القابلية الوراثية للتاموكسيفين من خلال مبدأ الدواء المساعد [Added title page title]

Subject(s):

Dissertation note: Thesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmaceutical Chemistry Summary: Selective estrogen receptor modulatory (SERMs) are a class of compounds that can act as estrogen receptor (ER) agonists in some tissues while acting as ER antagonists in others. They represent one of the most important xlasses for the treatment of breast cancer, osteoporosis, ovulatory infertility and cardiovascular disease. Tamoxifen was the first SERM to be used in the treatment of metastatic breast cancer. Tamoxifen has evolved as an agent used in all stages of breast cancer especially ER-positive treast cancer, over the past 30 years

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Status	Date due	Barcode
Thesis	قاعة الثقاقات الاجنبية - الدور الثالث	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.34.M.Sc.2016.No.C (Browse shelf(Opens below))	Not for loan		01010110072438000

Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	Cai01.34.M.Sc.2016.Na.A The association of thrombospondin-1 A2210G gene polymorphism with the oncidence of acute myocardial infarction in Egyptians /	Cai01.34.M.Sc.2016.Na.C Corporate disclosure via corporate websites and social media websites : Evidence from Australia /	Cai01.34.M.Sc.2016.Na.N Nover modulators of neuronal glycine receptors from kava (piper methysticum) root extract /	Cai01.34.M.Sc.2016.No.C Circumventing the genetic susceptibility of tamoxifen through pro-drug principle /	Cai01.34.M.Sc.2016.No.I The ipmact of privatization of state-owned banks on banking performance in the MENA region /	Cai01.34.M.Sc.2016.No.I Investigating the association of genetic variants of A387P thrombospondin-4 with acute myocardial infarction in Egyptians /	Cai01.34.M.Sc.2016.No.O On the use of graded propositions in uncertain non-mamotonic reasoning : With an application to plant disease forecast /	Next

Thesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmaceutical Chemistry

Selective estrogen receptor modulatory (SERMs) are a class of compounds that can act as estrogen receptor (ER) agonists in some tissues while acting as ER antagonists in others. They represent one of the most important xlasses for the treatment of breast cancer, osteoporosis, ovulatory infertility and cardiovascular disease. Tamoxifen was the first SERM to be used in the treatment of metastatic breast cancer. Tamoxifen has evolved as an agent used in all stages of breast cancer especially ER-positive treast cancer, over the past 30 years

There are no comments on this title.

to post a comment.